Navigation Links
Sachs in Medical News

Covance to Present at Goldman Sachs Thirtieth Annual Global Healthcare Conference

PRINCETON, N.J., June 10 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced that it will present at Goldman Sachs Thirtieth Annual Global Healthcare Conference on Thursday, June 11, 2009 at 10:20 a.m. (ET). Investors may access a live webcast of the presentation at www.covanc...

Amgen to Present at the Goldman Sachs Global Healthcare Conference

THOUSAND OAKS, Calif., June 8 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN ) will present at the Goldman Sachs Global Healthcare Conference on Wednesday, June 10, 2009 at the Grand Hyatt, New York City, N.Y., beginning at 9:00 a.m. Eastern Time. Roger M. Perlmutter, Amgen's Executive Vice Pres...

Warner Chilcott to Present at the Goldman Sachs 30th Annual Healthcare Conference

ARDEE, Ireland, June 8 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX ) announced today that it will present at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 10:20 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, Presiden...

Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference

CHADDS FORD, Pa., June 5 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it will present at the Goldman Sachs 30th Annual Healthcare Conference on Wednesday, June 10, 2009 at 4:30 pm Eastern Time. Dave Holveck, President and Chief Executive Officer of Endo, w...

Abbott to Present at Goldman Sachs Global Healthcare Conference

ABBOTT PARK, Ill., June 1 /PRNewswire-FirstCall/ -- Abbott will present at the Goldman Sachs 30th Annual Global Healthcare Conference on Wednesday, June 10, 2009. Miles D. White, chairman and chief executive officer, and Thomas C. Freyman, executive vice president, finance and chief financial offi...

Beckman Coulter to Present at the 2009 Goldman Sachs Healthcare Conference

ORANGE COUNTY, Calif., May 29 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Allan Harris, Beckman Coulter's vice president of strateg...

Air Products' CEO to Address Goldman Sachs Basic Materials Conference on 4 June

LEHIGH VALLEY, Pa., May 28 /PRNewswire-FirstCall/ -- Air Products (NYSE: APD ) announced today that Chairman, President and Chief Executive Officer John E. McGlade will be presenting at the Goldman Sachs Basic Materials Conference in New York on Thursday, June 4, 2009, at 8:00 a.m. EDT. An...

PAREXEL International to Present at Goldman Sachs Annual Global Healthcare Conference and the Jefferies Annual Healthcare Conference

BOSTON, May 28 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Goldman Sachs 30th Annual Global Healthcare Conference in New York. Josef von Rickenbach, Chairman & Chief Executive Officer will be making a formal presen...

Hill-Rom to Participate in the Goldman Sachs 30th Annual Global Healthcare Conference

BATESVILLE, Ind., May 26 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc., (NYSE: HRC ) invites you to listen to a discussion with Peter H. Soderberg, president and chief executive officer, Hill-Rom. He will be participating in the Goldman Sachs 30th Annual Healthcare Conference in New York Ci...

Inverness Medical Innovations to Participate at Goldman Sachs Leveraged Finance Healthcare Conference on April 8, 2009

WALTHAM, Mass., April 4 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the upcoming Goldm...
Sachs in Medical Technology

Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences

PRINCETON, N.J., June 2 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (Nasdaq: VRUS ) announces management will present at the Goldman Sachs Global Healthcare Conference and the Needham Healthcare Conference. Both conferences will be held in New York, NY. Schaefer Price, Pharmasset's President...

Circassia Begins Phase II Clinical Trial With Ragweed Allergy Therapy

...mpany is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman sachs and Invesco Perpetual. For more information please visit http://www.circassia.co.uk. Contacts: Steve Harris Rob Budge CEO RJB...

Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients

...mpany is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman sachs and Invesco Perpetual. For more information please visit http://www.circassia.co.uk. Contacts Steve Harris Rob Budge...

Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment

...ounds is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman sachs and Invesco Perpetual. Circassia's anti-allergy products offer potential important clinical benefits compared with existing therapies, and cons...

Texas Back Institute Leads Way in New Facet Joint Clinical Trial

...inical trial of the Total Facet Arthroplasty System (TFAS)(R). Dr. Barton sachs of Texas Back Institute performed the TFAS procedure on Ron Kaipus in Septe...uture of the trial." There are openings within the clinical trial and Dr. sachs explained that patients affected with spinal stenosis or spondylolisthesis ...

Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology

...ounds is backed by a syndicate of world-class venture capital and institutional investors, including Imperial Innovations, Lansdowne Partners, Goldman sachs and Invesco Perpetual. Circassia's lead products target allergies utilizing the company's proprietary T-cell epitope desensitization technology, Tol...

Study Sheds Light on Medication Treatment Options for Bipolar Disorder

... adjusted participants mood stabilizer doses to optimal levels, ensuring that they were receiving the most appropriate amount. After about 26 weeks, sachs and colleagues found that 24 percent of those who had been randomized to the antidepressants stayed well for at least eight consecutive weeks — ...
Sachs in Medical Definition

Wolf Prize in Medicine

... 1978 George D. Snell , Jean Dausset , Jon J. van Rood 1979 Roger W. Sperry , Arvid Carlsson , Oleh Hornykiewicz 1980 Cesar Milstein , Leo sachs , Sir James L. Gowans 1981 Barbara McClintock , Stanley N. Cohen 1982 Jean-Pierre Changeux , Solomon H. Snyder , Sir James W. Black 1983...
Sachs in Medical Dictionary

Tay-sachs

... Tay - sachs disease is a genetic disorder, fatal in its most common variant known as Infantile Tay - sachs disease. TSD is inherited in an autosomal recess...c defect in a single gene and one... Tay - sachs disease is an autosomal recessive genetic dis...

Tay-Sachs disease

... Tay - sachs disease is an autosomal recessive genetic d... its most common variant known as infantile Tay - sachs disease it presents with a relentless deteriora...sical abilities which commences at 6... Tay - sachs disease is a genetic disorder, fatal in its m...

Autosomal recessive

.... Autosomal dominant inheritance. Autosomal recessive inheritance ... Home Autosomal Recessive : Cystic Fibrosis, Sickle Cell Anemia, Tay sachs Disease ... Many autosomal recessive conditions occur this way. ... Autosomal recessive ; Savannah Georgia GA, South Carolina SC St. Joseph...
Sachs in Biological News

Stanford launches $100 million initiative to tackle energy issues

...nded Farallon in 1986. He is also managing director of Hellman & Friedman, a San Francisco-based private equity firm. He previously worked for Goldman sachs and Morgan Stanley & Co. He is a graduate of the Stanford Graduate School of Business. Taylor earned a joint JD/MBA degree from the Stanford Law Schoo...

A happy new year for penguins

...nique wildlife. WCS manages some 740,000 acres of wilderness on the Chilean side of Tierra del Fuego, part of a major donation of land made by Goldman sachs in 2004. ...

bioMETRX, Inc. Welcomes Residential and Commercial Security Expert to Board of Directors

...eywell International, Inc., ASSA ABLOY Door Security Solutions, Diebold, Inc., BOSCH, NetApp, SimplexGrinnel LLC, General Electric Company and Goldman sachs & Company. Frank's experience involved working with those clients to recognize critical security issues, architecting and designing comprehensive solu...

Study of guanacos launched in Chile

...iversity of the area.. Donated to WCS by Goldman sachs in 2004, Karukinka consists of 740,000 acres of wi...ogs, unique river systems, and grasslands. Goldman sachs has provided key funding for this guanaco study. ...ndering over large landscapes. We commend Goldman sachs for their support to help protect an iconic specie...

Now is Africa's turn for a green revolution, global experts say

...about U.S. food aid policy as shipping food is more expensive than raising crops locally. In his talk, The Economics of the African Green Revolution, sachs will draw on his work to end world poverty and hunger in discussing effective strategies for progress in Africa. Currently, he is special advisor to U...

UD hosts conference on knowledge-based partnerships Nov. 2

... Chad Holliday, chairman and chief executive officer of DuPont, and Abby Joseph Cohen, partner and chief U.S. investment strategist with Goldman sachs & Co., will be featured speakers at a University of Delaware conference, Creating Knowledge-Based Partnerships: Challenges and Opportunities, to be he...

Public Library of Science to launch new, open access journal on neglected tropical diseases

...y experts from developing countries, and some of the biggest names in tropical medicine and global health, including renowned health economist Jeffrey sachs and the director of the World Health Organization's African river blindness control program, Uche Amazigo. Dr. Amazigo said: "PLoS Neglected Tropi...

UCLA scientists store materials in cells natural vaults

...s directly to a tumor cell without harming healthy tissue * Enzyme delivery to replace missing or defective enzymes, such as those that cause Tay sachs disease * DNA delivery to correct genetic mutations * Timed release of drugs, enzymes and DNA * Extracting and imprisoning cellular tox...

Potential treatments for neurofibromatosis

...ently little can be done to treat a disease that affects more people than cystic fibrosis, hereditary muscular dystrophy, Huntington's disease and Tay sachs combined. Now, however, research by IU School of Medicine scientist D. Wade Clapp, M.D., and his colleagues David A. Ingram, Jr., M.D. and Feng-Chu...
Sachs in Biological Technology

Amylin Pharmaceuticals to Present at Goldman Sachs Annual Global Health Care Conference

SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Goldman Sachs Annual Global Health Care Conference on Tuesday, June 9, 2009 at 10:45 a.m. ET / 7:45 a.m. PT in New York. Daniel M. Bradbury, president and chief executive officer...

InterMune to Present at Goldman Sachs Healthcare Conference

BRISBANE, Calif., June 3 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that Daniel Welch, Chairman, Chief Executive Officer and President of InterMune, will present at the Goldman Sachs 30th Annual Global Healthcare Conference in New York on June 9, 2009 at 2:35 p.m. ...

BioMarin to Present at the Goldman Sachs Healthcare Conference

NOVATO, Calif., June 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Jean-Jacques Bienaime, Chief Executive Officer of BioMarin, will present a company update at the Goldman Sachs 30th Annual Global Healthcare Conference in New York City on Tuesday, ...

Wyeth to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference

MADISON, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE ) announced today that it will present at the Goldman Sachs Healthcare CEOs Unscripted Conference on Wednesday, January 7, 2009 at 8:05 a.m. Eastern Time. Presenting for Wyeth will be Bernard Poussot, Chairman, President and Chief...

BioMS Medical to present at Sachs Associates Biotech in Europe Forum

Toronto Stock Exchange Symbol: MS EDMONTON, Sept. 19 /PRNewswire-FirstCall/ - BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that Mr. Tony Hesby, Executive Vice President, Corporate Affairs, will present at the Sachs Associates ...

Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008

WALTHAM, Mass., Sept. 16 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA ), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, today announced that Ron Zwanziger, Chairman, Chief Executive Officer and President,...

InterMune to Present at Goldman Sachs Healthcare and Needham & Co. Biotechnology and Medical Technology Conferences

BRISBANE, Calif., June 6 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that John Hodgman, Senior Vice President and Chief Financial Officer of InterMune, will present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference in Dana Point, Calif. on Jun...

Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference

SAN DIEGO, June 5 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ) will be presenting at the Goldman Sachs Global Healthcare Conference in Dana Point on Wednesday, June 11, 2008 at 1:20 p.m. PT. Daniel M. Bradbury, President and Chief Executive Officer of Amylin Pharmace...

Boston Scientific to Participate in Goldman Sachs Conference

NATICK, Mass., June 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX ) is scheduled to participate in Goldman Sachs' Annual Healthcare Conference, which is being held June 9-12 in Dana Point, CA. Jim Tobin, Boston Scientific Chief Executive Officer, will make a 10-minute...

PAREXEL International to Present at Goldman Sachs 29th Annual Global Healthcare Conference

BOSTON, June 5 /PRNewswire-FirstCall/ -- PAREXEL International Corporation (Nasdaq: PRXL ) announced today it will be presenting at the Goldman Sachs 29th Annual Global Healthcare Conference at The Ritz Carlton - Laguna Niguel in Dana Point, California. James Winschel, Senior Vice President a...
Other Tags
(Date:7/13/2014)... Recently, 2014QuinceaneraDresses.com, the distinguished special ... new range of gorgeous Quinceanera dresses . ... for elegant Quinceanera outfits is huge. Therefore, 2014QuinceaneraDresses.com ... the company’s newly released dresses are made according ... elegant and vivid. , It is worthy ...
(Date:7/13/2014)... imaging device developed at Cedars-Sinai can provide early ... brain and are a classic sign of Alzheimer,s ... a clinical trial in Australia. , The researchers ... oral presentation at the Alzheimer,s Association International Conference ... by conference organizers to participate in a "breaking ...
(Date:7/13/2014)... 2014 Celebrity fitness trainer and former ... promotional partnership with Aqua Health Labs for their flagship ... supplement . The collaboration was recently announced live on ... trainer , actor, model, and a two time World ... celebrities, he has prepared stars including Demi Moore, Hilary ...
(Date:7/13/2014)... Seattle, Wa (PRWEB) July 13, 2014 ... updated by Vkool.com, this is a comprehensive guide that ... to deal with KP (keratosis pilaris). This ...     Chapter 1: What Is Keratosis Pilaris? ,     Chapter ... Do I Know If I Have KP? , ...
(Date:7/12/2014)... July 12, 2014 The Chicken ... the past five years, buoyed by stable demand for ... management system. “Eggs are a relatively affordable staple for ... egg consumption generally grows in line with the size ... McKitterick. Furthermore, demand for new specialty egg products with ...
Breaking Medicine News(10 mins):Health News:2014QuinceaneraDresses.com Releases Its New Quinceanera Dresses 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 2Health News:Study of noninvasive retinal imaging device presented at Alzheimer's conference 3Health News:Celebrity Fitness Expert Supports Revolutionary New Health Supplement 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 2Health News:Living With KP Book Review Exposes Jennifer Richards' Keratosis Pilaris Guide – Vkool.com 3Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3
(Date:7/11/2014)... Research awarded Michael F. Holick, PhD, MD, of Boston ... V. Avioli Award. Holick, a professor of medicine, physiology ... the understanding of vitamin D and its role in ... of the American Society for Bone and Mineral Research ... research. It is named for ASBMR,s first president and ...
(Date:7/11/2014)... USC Stem Cell scientists have set a "mouse TRAP" ... described by a recent study published in the ... line uses a technique called TRAP to extract cellular ... , Invented by scientists at the Rockefeller Institute for ... tag to the protein-making machinery, or ribosomes, of the ...
(Date:7/11/2014)... Shenzhen, China Researchers from Salk Institute for Biological ... time evaluated the safety and reliability of the ... a new method, TALEN-HDAdV, which could significantly increased ... (hiPSC). This study published online in Cell ... for stem cell-based gene therapy. , The combination ...
Breaking Biology News(10 mins):BUSM's Michael F. Holick receives American Society for Bone and Mineral Research award 2A new genome editing method brings the possibility of gene therapies closer to reality 2
Other Contents